Stallergenes Greer enters partnership to develop device and app

Stallergenes Greer and Aptar Pharma will collaborate to develop a new connected device with a companion app for patients going through treatment with the allergy company's allergen immunotherapy.

Photo: Joachim Adrian

The allergy company Stallergenes Greer has entered into a partnership with Aptar Pharma regarding the development of a novel connected device and a companion mobile app, the former reports in a press release.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs